1Zielinski G, Podgorski JK. Acromegaly-do we already know everything about treatment of the somatotroph pituitary adenomas ? [J]. Przegl Lek, 2002, 59(7): 540-547. 被引量：1
2Tyrrell JB, Lamborn KR, Hannegan LT, et al. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results [J]. Neurosurgery, 1999, 44(2): 254-261. 被引量：1
3Colao A, Ferone D, Marzullo P, et al. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly [J]. J Clin Endocrinol Metab, 2001, 86(6): 2779-2786. 被引量：1
4Tella OI Jr, Herculano MA, Delcello R, et al. Growth pituitary adenomas: evaluation of 20 patients [J]. Arq Neuropsiquiatr, 2002, 60(1): 123-128. 被引量：1
6Beauregard C, Truong U, Hardy J, et al. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly [J]. Clin Endocrinol(Oxf), 2003, 58(1): 86-91. 被引量：1
7Abe T, Ludecke DK. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical center [J]. Eur J Endocrinol, 2001, 145(2): 137-145. 被引量：1
8Perrin G, Stevenaert A, Jouanneau E.Technical aspects and surgical strategy for removal of corticotroph pituitary adenoma [J]. Neurochirurgie, 2002, 48(2-3Pt2): 186-214. 被引量：1
10Flitsch J, Knappe UJ, Ludecke DK.The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease [J]. Zentralbl Neurochir, 2003, 64(1): 6-11. 被引量：1
10Stratakis C A, Tichomirowa M A, Boikos S, et al. The role of germline AIP, MEN1. PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes[J]. Clin Genet,2010,78(5) :457 -463. 被引量：1
